Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Gliesche DG"'
Autor:
Prestin K, Olbert M, Hussner J, Isenegger TL, Gliesche DG, Böttcher K, Zimmermann U, Meyer zu Schwabedissen HE
Publikováno v:
OncoTargets and Therapy, Vol 2016, Iss Issue 1, Pp 4867-4878 (2016)
Katharina Prestin,1,* Maria Olbert,2,* Janine Hussner,1 Tamara L Isenegger,1 Daniel G Gliesche,1 Kerstin Böttcher,2 Uwe Zimmermann,3 Henriette E Meyer zu Schwabedissen1 1Department of Pharmaceutical Sciences, Biopharmacy, University of Basel, Basel,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::d10367ccbc4e5d0b9ac4ccb26270380b
https://www.dovepress.com/modulation-of-expression-of-the-nuclear-receptor-nr0b2-small-heterodim-peer-reviewed-article-OTT
https://www.dovepress.com/modulation-of-expression-of-the-nuclear-receptor-nr0b2-small-heterodim-peer-reviewed-article-OTT
Autor:
Hussner J; Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 50, 4056 Basel, Switzerland., Sünwoldt J; Institute of Pharmacology, Center of Drug Absorption and Transport, University Medicine, Ernst Moritz Arndt University Greifswald, Felix-Hausdorff-Strasse 3, 17489 Greifswald, Germany., Seibert I; Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 50, 4056 Basel, Switzerland., Gliesche DG; Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 50, 4056 Basel, Switzerland., Zu Schwabedissen HE; Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 50, 4056 Basel, Switzerland. Electronic address: h.meyerzuschwabedissen@unibas.ch.
Publikováno v:
European journal of pharmacology [Eur J Pharmacol] 2016 Aug 05; Vol. 784, pp. 137-46. Date of Electronic Publication: 2016 May 19.
Autor:
Gliesche DG; Biopharmacy, Department of Pharmaceutical Sciences, University of Basel , 4056 Basel, Switzerland., Hussner J; Biopharmacy, Department of Pharmaceutical Sciences, University of Basel , 4056 Basel, Switzerland., Witzigmann D; Pharmaceutical Technology, Department of Pharmaceutical Sciences, University of Basel , Basel 4056, Switzerland., Porta F; Pharmaceutical Technology, Department of Pharmaceutical Sciences, University of Basel , Basel 4056, Switzerland., Glatter T; Proteomics Core Facility, Biozentrum, University of Basel , Basel 4056, Switzerland., Schmidt A; Proteomics Core Facility, Biozentrum, University of Basel , Basel 4056, Switzerland., Huwyler J; Pharmaceutical Technology, Department of Pharmaceutical Sciences, University of Basel , Basel 4056, Switzerland., Meyer Zu Schwabedissen HE; Biopharmacy, Department of Pharmaceutical Sciences, University of Basel , 4056 Basel, Switzerland.
Publikováno v:
Molecular pharmaceutics [Mol Pharm] 2016 Jul 05; Vol. 13 (7), pp. 2290-300. Date of Electronic Publication: 2016 Jun 09.
Expression of OATP2B1 as determinant of drug effects in the microcompartment of the coronary artery.
Autor:
Hussner J; University of Basel, Department of Pharmaceutical Sciences, Biopharmacy, Basel, Switzerland., Begunk R; University Medicine, Ernst Moritz Arndt University Greifswald, Center of Drug Absorption and Transport, Institute of Pharmacology, Greifswald, Germany., Boettcher K; University Medicine, Ernst Moritz Arndt University Greifswald, Center of Drug Absorption and Transport, Institute of Pharmacology, Greifswald, Germany., Gliesche DG; University of Basel, Department of Pharmaceutical Sciences, Biopharmacy, Basel, Switzerland., Prestin K; University of Basel, Department of Pharmaceutical Sciences, Biopharmacy, Basel, Switzerland., Meyer Zu Schwabedissen HE; University of Basel, Department of Pharmaceutical Sciences, Biopharmacy, Basel, Switzerland. Electronic address: h.meyerzuschwabedissen@unibas.ch.
Publikováno v:
Vascular pharmacology [Vascul Pharmacol] 2015 Sep; Vol. 72, pp. 25-34. Date of Electronic Publication: 2015 Jun 16.